Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Italy News Dispatch.
Press releases published on April 16, 2025
Margaret's the Couture Cleaner to participate in World Leather Day on April 26, 2025"
EIN Presswire
·
April 16, 2025
This global celebration highlights leather's unique qualities while promoting transparency, sustainability, and longevity in the industry. LOS ANGELES, CA, UNITED STATES, April 16, 2025 /EINPresswire.com/ -- Margret's the Couture Cleaner, the nation's …
Liguria: nel 2024 gli acquirenti stranieri superano gli italiani nel mercato immobiliare
EIN Presswire
·
April 16, 2025
Nel 2024 il 54% delle vendite è stato effettuato da stranieri, con prezzi in crescita e forte domanda per le case di pregio in Liguria. SANREMO, LIGURIA, ITALY, April 16, 2025 /EINPresswire.com/ -- Il mercato immobiliare della Riviera di Ponente si …
Olon Receives 2025 CMO Excellence in Green Chemistry Award
GlobeNewswire
·
April 16, 2025
RODANO, Italy, April 16, 2025 (GLOBE NEWSWIRE) -- Olon S.p.A. is honored to announce its receipt of the esteemed 2025 CMO Excellence in Green Chemistry Award. This accolade, conferred by the ACS Green Chemistry Institute Pharmaceutical Roundtable (ACS …
Iveco Group announces the results of the Annual General Meeting
GlobeNewswire
·
April 16, 2025
Turin, 16th April 2025. Iveco Group N.V. (EXM: IVG) (the Company) announces that its shareholders approved all the resolutions proposed by the Board of Directors (the Board) at its Annual General Meeting (AGM) held today in Amsterdam, the Netherlands. At …
FERRARI ANNOUNCES VOTING RESULTS FROM ITS ANNUAL GENERAL MEETING
GlobeNewswire
·
April 16, 2025
Maranello (Italy), 16 April 2025 - Ferrari N.V. (“Ferrari” or the “Company”) (NYSE/EXM: RACE) announced today that all resolutions proposed to Shareholders at the Ferrari’s Annual General Meeting of Shareholders (the “AGM”) held today in Amsterdam, the …
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME
GlobeNewswire
·
April 16, 2025
RECORDATI: FDA GRANTS ISTURISA® (OSILODROSTAT) EXPANDED INDICATION FOR THE TREATMENT OF ENDOGENOUS HYPERCORTISOLEMIA IN PATIENTS WITH CUSHING’S SYNDROME ISTURISA® is a cortisol synthesis inhibitor that blocks the enzyme 11β-hydroxylase to help normalize …